Enanta Pharmaceuticals, Inc. (ENTA)

Enanta Pharmaceuticals Stock Forecast

Stock Price Forecast

The 4 analysts that cover Enanta Pharmaceuticals stock have a consensus rating of "Buy" and an average price target of $18, which forecasts a 148.96% increase in the stock price over the next year. The lowest target is $10 and the highest is $24.

Price Target: $18 (+148.96%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$10	$18	$20	$24
Change	+38.31%	+148.96%	+176.63%	+231.95%

Analyst Ratings

The average analyst rating for Enanta Pharmaceuticals stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Jan '25	Feb '25	Mar '25	Apr '25	May '25	Jun '25
Strong Buy	1	1	1	1	1	1
Buy	2	2	2	2	2	2
Hold	0	0	0	0	0	0
Sell	1	1	1	1	1	1
Strong Sell	0	0	0	0	0	0
Total	4	4	4	4	4	4

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Roy Buchanan JMP Securities	JMP Securities	Buy Maintains $23 → $24	Buy	Maintains	$23 → $24	+231.95%	Jun 3, 2025
Roy Buchanan JMP Securities	JMP Securities	Buy Reiterates $21	Buy	Reiterates	$21	+190.46%	Feb 11, 2025
Ed Arce HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $18	Strong Buy	Reiterates	$18	+148.96%	Feb 11, 2025
Ed Arce HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $27 → $18	Strong Buy	Maintains	$27 → $18	+148.96%	Dec 24, 2024
Brian Skorney Baird	Baird	Buy Maintains $26 → $20	Buy	Maintains	$26 → $20	+176.63%	Nov 26, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

64.03M

Decreased by -5.33%

from 67.64M

Revenue Next Year

64.34M

Increased by 0.48%

from 64.03M

EPS This Year

-4.36

from -5.48

EPS Next Year

-4.36

from -4.36

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Sep 30, 2020	Sep 30, 2021	Sep 30, 2022	Sep 30, 2023	Sep 30, 2024	Sep 30, 2025	Sep 30, 2026	Sep 30, 2027
Revenue	122.47M	97.07M	86.16M	79.20M	67.64M	64.03M	64.34M	62.42M
Revenue Growth	-40.31%	-20.74%	-11.24%	-8.07%	-14.61%	-5.33%	0.48%	-2.97%
EPS	-1.81	-3.92	-5.91	-6.38	-5.48	-4.36	-4.36	-4.40
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	9	8	5

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029
High	68.8M	73.4M	69.7M
Avg	64.0M	64.3M	62.4M
Low	60.5M	56.8M	54.9M

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029
High	1.7%	14.6%	8.4%
Avg	-5.3%	0.5%	-3.0%
Low	-10.6%	-11.2%	-14.7%

EPS Forecast

EPS	2025	2026	2027	2028
High	-2.70	-2.21	-1.47
Avg	-4.36	-4.36	-4.40
Low	-6.16	-9.31	-9.60

EPS Growth

EPS Growth	2025	2026	2027	2028
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.